ConductScience.org, home

Paper34638457

Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.

Kumar S and 2 others. Cancers (Basel), 2021. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic. Papers, record 34638457. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34638457

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2023-09-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumar SSanjeevhttps://orcid.org/0000-0001-6017-1117
2Freelander AAllegrahttps://orcid.org/0000-0003-4213-6451
3Lim EElgenehttps://orcid.org/0000-0001-8065-8838

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References168

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123238854Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.Endocr Rev2013https://conductscience.org/library/papers/23238854PubMed
230557851Non-canonical AR activity facilitates endocrine resistance in breast cancer.Endocr Relat Cancer2019https://conductscience.org/library/papers/30557851PubMed
316604168The cell-specific activity of the estrogen receptor alpha may be fine-tuned by phosphorylation-induced structural gymnastics.Nucl Recept Signal2006https://conductscience.org/library/papers/16604168PubMed
429899353A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes.Nat Commun2018https://conductscience.org/library/papers/29899353PubMed
526122181ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.Nat Rev Clin Oncol2015https://conductscience.org/library/papers/26122181PubMed
629514843The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome.Clin Cancer Res2018https://conductscience.org/library/papers/29514843PubMed
727885264Deciphering the divergent roles of progestogens in breast cancer.Nat Rev Cancer2017https://conductscience.org/library/papers/27885264PubMed
86216931Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies.Breast Cancer Res Treat1981https://conductscience.org/library/papers/6216931PubMed
926169690DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.Nat Commun2015https://conductscience.org/library/papers/26169690PubMed
1024451109Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.Breast Cancer Res2014https://conductscience.org/library/papers/24451109PubMed
1131353221Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility.Cell2019https://conductscience.org/library/papers/31353221PubMed
1224016618Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.Clin Cancer Res2013https://conductscience.org/library/papers/24016618PubMed
1318071186Vitamin D intake and breast cancer risk in postmenopausal women.Arch Intern Med2007https://conductscience.org/library/papers/18071186PubMed
143975652Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.Semin Oncol1985https://conductscience.org/library/papers/3975652PubMed
1531474332Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.Lancet2019https://conductscience.org/library/papers/31474332PubMed
1621559012A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.Br J Cancer2011https://conductscience.org/library/papers/21559012PubMed
176225476Current status of high dose progestin treatment in advanced breast cancer.Breast Cancer Res Treat1983https://conductscience.org/library/papers/6225476PubMed
1829991605Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer.Cancer Discov2018https://conductscience.org/library/papers/29991605PubMed
1914745018Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/14745018PubMed
2024480385Retinoids and breast cancer: from basic studies to the clinic and back again.Cancer Treat Rev2014https://conductscience.org/library/papers/24480385PubMed

See all 168 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
38973256Double Imprinted Nanoparticles for Sequential Membrane-to-Nuclear Drug Delivery.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38973256PubMed
38717954Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/38717954PubMed
38124194Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.BMC Pharmacol Toxicol2023https://conductscience.org/library/papers/38124194PubMed
37019926Impaired retinoic acid signaling in cerebral cavernous malformations.Sci Rep2023https://conductscience.org/library/papers/37019926PubMed
36661673The Role of Glucocorticoids in Breast Cancer Therapy.Curr Oncol2022https://conductscience.org/library/papers/36661673PubMed
35761157Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression.Cancer Metastasis Rev2022https://conductscience.org/library/papers/35761157PubMed
35626007Nuclear Receptor Coregulators in Hormone-Dependent Cancers.Cancers (Basel)2022https://conductscience.org/library/papers/35626007PubMed
35450488Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer.Technol Cancer Res Treat2022https://conductscience.org/library/papers/35450488PubMed

Download CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
ESR22100PubTator's text mininghttps://conductscience.org/library/genes/2100NCBI Gene
H2AC188337PubTator's text mininghttps://conductscience.org/library/genes/8337NCBI Gene
H2AZ13015PubTator's text mininghttps://conductscience.org/library/genes/3015NCBI Gene
H2BC218349PubTator's text mininghttps://conductscience.org/library/genes/8349NCBI Gene
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
HOXC103226PubTator's text mininghttps://conductscience.org/library/genes/3226NCBI Gene
HSP90B2P7190PubTator's text mininghttps://conductscience.org/library/genes/7190NCBI Gene
KRT53852PubTator's text mininghttps://conductscience.org/library/genes/3852NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
NR3C12908PubTator's text mininghttps://conductscience.org/library/genes/2908NCBI Gene
NR3C24306PubTator's text mininghttps://conductscience.org/library/genes/4306NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene
PIK3CA5290PubTator's text mininghttps://conductscience.org/library/genes/5290NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34638457

GET https://conductscience.org/api/papers/v1/34638457/references?page=2